Dihydroquercetin Nanomicelles Mitigate Hippocampal Apoptosis and Alleviate Autism-Like Behaviors in ASD Rats via the IKK/IKB/NF-κB Signaling Pathway
Authors:
- 6 August 2025
- journal article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 22 (9) , 5443-5457
Abstract
Dihydroquercetin (DHQ), a compound with neuroprotective effects, has shown its potential in a variety of nervous system diseases. However, its mechanism of action in autism spectrum disorder (ASD) remains to be further explored. Due to its poor solubility, the clinical application of DHQ is restricted. In this study, we aimed to improve the solubility of DHQ by constructing a novel nanodrug delivery system. We utilized the amphiphilic block copolymer MANNOSE-PEG2000-DSPE to encapsulate DHQ, and the resulting formulation was abbreviated as MAN@DHQ. The ASD rats were treated with MAN@DHQ for 7 days. The results of in vivo experiments confirmed that MAN@DHQ could effectively alleviate autism-like behaviors of ASD rats. Western blot results demonstrated that MAN@DHQ mitigate hippocampal apoptosis and ameliorated neuronal damage in the hippocampus of ASD rats via the IKK/IKB/NF-κB signaling pathway. The therapeutic potential of MAN@DHQ in ASD treatment represents a paradigm-shifting advancement in autism pharmacotherapy and offers promise for clinical interventions for ASD patients.Keywords
Funding Information
- Regional Joint Fund of National Natural Science Foundation of China (U24A20770)
This publication has 30 references indexed in Scilit:
- Neuroprotective effects of Apigenin on prenatal Valproic acid-induced autism spectrum disorder in ratsIBRO Neuroscience Reports, 2024
- Genomic architecture of autism from comprehensive whole-genome sequence annotationCell, 2022
- Dihydroquercetin improves rotenone‐induced Parkinsonism by regulating NF‐κB‐mediated inflammation pathway in ratsJournal of Biochemical and Molecular Toxicology, 2022
- Dihydroquercetin ameliorates LPS-induced neuroinflammation and memory deficitCurrent Research in Pharmacology and Drug Discovery, 2022
- 48. A PHENOTYPIC SPECTRUM OF AUTISM IS ATTRIBUTABLE TO THE COMBINED EFFECTS OF RARE VARIANTS, POLYGENIC RISK AND SEXEuropean Neuropsychopharmacology, 2021
- Etiology of Autism Spectrum Disorders and Autistic Traits Over TimeJAMA Psychiatry, 2020
- The influence of neuroinflammation in Autism Spectrum DisorderBrain, Behavior, and Immunity, 2019
- The valproic acid-induced rodent model of autismExperimental Neurology, 2018
- Mannose-conjugated platinum complexes reveals effective tumor targeting mediated by glucose transporter 1Biochemical and Biophysical Research Communications, 2017
- Systematic Review of the Prevalence and Incidence of Intellectual Disabilities: Current Trends and IssuesCurrent Developmental Disorders Reports, 2016